Profil
Dana Redhair joined Oculus Innovative Sciences, Inc. as Vice President-Regulatory Affairs and Quality in June 2007.
Previously, he served as Vice President-Regulatory Affairs and Quality at SGX Pharmaceuticals and Executive Director-Regulatory Affairs at CancerVax Corporation.
Mr. Redhair held various key regulatory positions for Elan Pharmaceuticals, Chiron Corporation, Berlex Laboratories, Genentech and the UCSF Cancer Research Institute.
He received a BA degree in History and Science from Harvard University in 1981.
Anciens postes connus de Dana Redhair
| Sociétés | Poste | Fin |
|---|---|---|
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Conseiller Juridique Général | - |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Conseiller Juridique Général | - |
| SONOMA PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Formation de Dana Redhair
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
















